• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泰国患有普拉德-威利综合征的儿童生长图表 0-18 岁。

Growth charts for Thai children with Prader-Willi syndrome aged 0-18 years.

机构信息

Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

Division of Medical Genetics, Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Orphanet J Rare Dis. 2020 May 6;15(1):111. doi: 10.1186/s13023-020-01388-7.

DOI:10.1186/s13023-020-01388-7
PMID:32375863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7201534/
Abstract

BACKGROUND

Prader-Willi syndrome (PWS) is a multisystem genetic disorder, which has a typical eating behavior and growth pattern. In the infancy period, children with PWS have low body weight followed by hyperphagia in later childhood. Disease-specific growth charts have been recommended for monitoring PWS patients. Previous literature demonstrated growth differences among individuals with PWS of different ethnicity.

METHODS

A retrospective multicenter study was performed in PWS patients from different areas of Thailand included collaboration with the Thai PWS support group during 2000-2017. Baseline characteristics and anthropometric data were reviewed. Both growth hormone and non-growth hormone received patients were included, but the data after receiving GH were excluded before curve construction. Growth charts for Thai PWS compared to the 50th normative centile were constructed using Generalized Least Squares (GLS) methods. Curve smoothing was performed by Fractional Polynomials and Exponential Transformation.

RESULT

One hundred and thirteen patients with genetically confirmed PWS (55 males and 58 females) were enrolled. Fifty percent of patients were diagnosed less than 6 months of age. We developed growth charts for non-growth hormone treated Thai children with PWS aged between 0 and 18 years. A growth pattern was similar to other ethnicities while there were some differences. Mean birth weight of PWS patients was less than that of typical newborns. Mean adult height at 18 years of age in Thai children with PWS was lower than that in American children, but taller than Japanese. Mean weight of Thai PWS males at 18 years of age was more than those from other countries.

CONCLUSION

This study is the first to document PWS-specific growth charts in Southeast Asian population. These growth charts will be useful in improving the quality of patient care and in evaluating the impact of growth hormone treatment in the future.

摘要

背景

普拉德-威利综合征(PWS)是一种多系统遗传疾病,具有典型的饮食行为和生长模式。在婴儿期,PWS 患儿体重较低,随后在儿童后期出现食欲过盛。目前推荐使用专门针对疾病的生长图表来监测 PWS 患者。既往文献表明,不同种族的 PWS 患者存在生长差异。

方法

本研究为 2000 年至 2017 年间在泰国不同地区开展的一项回顾性多中心研究,与泰国 PWS 支持小组合作。对患者的基本特征和人体测量学数据进行了回顾。本研究纳入了接受过生长激素和非生长激素治疗的患者,但在构建曲线之前排除了接受生长激素治疗后的相关数据。采用广义最小二乘法(GLS)构建泰国 PWS 患者与第 50 个百分位数相比的生长图表。采用分数多项式和指数变换对曲线进行平滑处理。

结果

本研究共纳入 113 例经基因确诊的 PWS 患者(男性 55 例,女性 58 例),其中 50%的患者在 6 个月龄以内被诊断。本研究为 0 至 18 岁未接受生长激素治疗的泰国 PWS 患儿制定了生长图表。其生长模式与其他种族相似,但也存在一些差异。PWS 患儿的平均出生体重低于典型新生儿。泰国 PWS 患儿 18 岁时的平均成人身高低于美国患儿,但高于日本患儿。泰国 PWS 男性患儿 18 岁时的平均体重高于其他国家的患儿。

结论

本研究首次在东南亚人群中记录了 PWS 特异性生长图表。这些生长图表将有助于提高患者的护理质量,并在未来评估生长激素治疗的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/1162a7fb5411/13023_2020_1388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/ab4e3f8553fa/13023_2020_1388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/0b4e6562527f/13023_2020_1388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/cdab92bc1d5f/13023_2020_1388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/fa358a507d8e/13023_2020_1388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/1162a7fb5411/13023_2020_1388_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/ab4e3f8553fa/13023_2020_1388_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/0b4e6562527f/13023_2020_1388_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/cdab92bc1d5f/13023_2020_1388_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/fa358a507d8e/13023_2020_1388_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d5d/7201534/1162a7fb5411/13023_2020_1388_Fig5_HTML.jpg

相似文献

1
Growth charts for Thai children with Prader-Willi syndrome aged 0-18 years.泰国患有普拉德-威利综合征的儿童生长图表 0-18 岁。
Orphanet J Rare Dis. 2020 May 6;15(1):111. doi: 10.1186/s13023-020-01388-7.
2
Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.普拉德-威利综合征在生长激素治疗期间的生长图表
Clin Pediatr (Phila). 2016 Sep;55(10):957-74. doi: 10.1177/0009922815617973. Epub 2016 Feb 3.
3
Growth charts for non-growth hormone treated Prader-Willi syndrome.未经生长激素治疗的普拉德-威利综合征生长图表。
Pediatrics. 2015 Jan;135(1):e126-35. doi: 10.1542/peds.2014-1711. Epub 2014 Dec 8.
4
Disease-specific growth charts for Korean infants with Prader-Willi syndrome.针对患有普拉德-威利综合征的韩国婴儿的疾病特异性生长图表。
Am J Med Genet A. 2015 Jan;167A(1):86-94. doi: 10.1002/ajmg.a.36816. Epub 2014 Oct 22.
5
The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.生长激素治疗普拉德-威利综合征儿童及青少年的行为影响:一项为期2年的对照研究。
Pediatrics. 2002 Feb;109(2):E35. doi: 10.1542/peds.109.2.e35.
6
Growth standards of infants with Prader-Willi syndrome.普拉德-威利综合征婴儿的生长标准。
Pediatrics. 2011 Apr;127(4):687-95. doi: 10.1542/peds.2010-2736. Epub 2011 Mar 14.
7
The changing purpose of Prader-Willi syndrome clinical diagnostic criteria and proposed revised criteria.普拉德-威利综合征临床诊断标准的目的变化及修订标准建议
Pediatrics. 2001 Nov;108(5):E92. doi: 10.1542/peds.108.5.e92.
8
Outcomes of growth hormone treatment in children with Prader-Willi syndrome over a 30-year period: a single tertiary center experience.30 年来生长激素治疗普拉德-威利综合征儿童的结果:单中心经验。
J Pediatr Endocrinol Metab. 2024 Aug 1;37(8):680-685. doi: 10.1515/jpem-2024-0059. Print 2024 Aug 27.
9
Circulating insulin-like growth factor 1 levels are reduced in very young children with Prader-Willi syndrome independent of anthropometric parameters and nutritional status.普拉德-威利综合征幼儿的循环胰岛素样生长因子1水平降低,且与人体测量参数和营养状况无关。
Clin Endocrinol (Oxf). 2022 Mar;96(3):346-352. doi: 10.1111/cen.14635. Epub 2021 Nov 8.
10
Growth patterns of Chinese patients with Prader-Willi syndrome.中国普拉德-威利综合征患者的生长模式。
Congenit Anom (Kyoto). 2015 Nov;55(4):173-7. doi: 10.1111/cga.12111.

引用本文的文献

1
Recommendations for the diagnosis and management of childhood Prader-Willi syndrome in China.中国儿童普拉德-威利综合征诊断与管理建议。
Orphanet J Rare Dis. 2022 Jun 13;17(1):221. doi: 10.1186/s13023-022-02302-z.

本文引用的文献

1
Growth hormone therapy for Prader-willi syndrome: challenges and solutions.普拉德-威利综合征的生长激素治疗:挑战与解决方案
Ther Clin Risk Manag. 2016 Jun 2;12:873-81. doi: 10.2147/TCRM.S70068. eCollection 2016.
2
Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey.基于2000年全国调查的日本儿童生长标准图表,包含均值和标准差(SD)值。
Clin Pediatr Endocrinol. 2016 Apr;25(2):71-6. doi: 10.1297/cpe.25.71. Epub 2016 Apr 28.
3
Growth Charts for Prader-Willi Syndrome During Growth Hormone Treatment.
普拉德-威利综合征在生长激素治疗期间的生长图表
Clin Pediatr (Phila). 2016 Sep;55(10):957-74. doi: 10.1177/0009922815617973. Epub 2016 Feb 3.
4
Growth patterns of Chinese patients with Prader-Willi syndrome.中国普拉德-威利综合征患者的生长模式。
Congenit Anom (Kyoto). 2015 Nov;55(4):173-7. doi: 10.1111/cga.12111.
5
Growth charts for non-growth hormone treated Prader-Willi syndrome.未经生长激素治疗的普拉德-威利综合征生长图表。
Pediatrics. 2015 Jan;135(1):e126-35. doi: 10.1542/peds.2014-1711. Epub 2014 Dec 8.
6
Disease-specific growth charts for Korean infants with Prader-Willi syndrome.针对患有普拉德-威利综合征的韩国婴儿的疾病特异性生长图表。
Am J Med Genet A. 2015 Jan;167A(1):86-94. doi: 10.1002/ajmg.a.36816. Epub 2014 Oct 22.
7
Worldwide variation in human growth and the World Health Organization growth standards: a systematic review.全球人类生长差异与世界卫生组织生长标准:一项系统评价。
BMJ Open. 2014 Jan 8;4(1):e003735. doi: 10.1136/bmjopen-2013-003735.
8
Endocrine manifestations and management of Prader-Willi syndrome.普拉德-威利综合征的内分泌表现及管理
Int J Pediatr Endocrinol. 2013 Aug 21;2013(1):14. doi: 10.1186/1687-9856-2013-14.
9
Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome.生长激素治疗 Prader-Willi 综合征儿童的长期效果。
Curr Opin Pediatr. 2013 Aug;25(4):509-14. doi: 10.1097/MOP.0b013e328362c7a2.
10
GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.生长激素研究学会研讨会总结:普瑞德威利综合征重组人生长激素治疗共识指南。
J Clin Endocrinol Metab. 2013 Jun;98(6):E1072-87. doi: 10.1210/jc.2012-3888. Epub 2013 Mar 29.